Artikel ; Online: Ongoing Measles in the Developed and Developing World.
Journal of the Pediatric Infectious Diseases Society
2024 Band 13, Heft 4, Seite(n) 233–236
Abstract: Measles is a vaccine-preventable illness. Nevertheless, in recent years, measles is still endemic and epidemic in both the developed world and the developing world. The public perception of measles in the past was that it was not a big deal. However, ... ...
| Abstract | Measles is a vaccine-preventable illness. Nevertheless, in recent years, measles is still endemic and epidemic in both the developed world and the developing world. The public perception of measles in the past was that it was not a big deal. However, measles is associated with a number of complications which can be places in three categories which are: acute(diarrhea, otitis media, pneumonia, encephalitis, seizures, and death) and delayed-subacute sclerosing panencephalitis (SSPE) and post-measles immune amnesia. Contrary to the beliefs of the anti-vaccine lobby, measles is bad. In acute measles, the death rate is 1-3 per 1000 and the risk of encephalitis is 1 per 1000. Relatively recent investigations indicate that SSPE is considerably more common than previously believed. The worldwide contribution of post-measles immune amnesia to morbidity and mortality is likely to be huge. In exposure situations, two doses of measles vaccine will prevent 99% of cases. Presently in the United States, the first dose is given at 12 through 15 months of age. The second dose is most often administered at 4 through 6 years of age. In my opinion, the second dose of measles vaccine should be given 4-6 weeks after the first dose rather than at 4-6 years of age. Children who don't have antibody to measles should not travel to risk areas. |
|---|---|
| Mesh-Begriff(e) | Humans ; Measles/prevention & control ; Measles/epidemiology ; Measles Vaccine/administration & dosage ; Developing Countries ; Developed Countries ; Child ; Subacute Sclerosing Panencephalitis/prevention & control ; Subacute Sclerosing Panencephalitis/immunology ; Infant ; Child, Preschool ; Immunization Schedule ; Vaccination |
| Chemische Substanzen | Measles Vaccine |
| Sprache | Englisch |
| Erscheinungsdatum | 2024-02-29 |
| Erscheinungsland | England |
| Dokumenttyp | Journal Article ; Review |
| ZDB-ID | 2668791-4 |
| ISSN | 2048-7207 ; 2048-7193 |
| ISSN (online) | 2048-7207 |
| ISSN | 2048-7193 |
| DOI | 10.1093/jpids/piae018 |
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.